Conakry

Resilience System


You are here

Public Health

New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.

..

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Public Health
howdy folks
Page loaded in 1.161 seconds.